GT Biopharma Inc. (GTBP) Update
GT Biopharma (GTBP) has been on our radar for months now and with several key catalysts including a potential Nasdaq Uplisting that could be coming up in the near future, 2018 could be setting up to become a VERY strong year!
Gene Therapy Now Has Found Its Place In Modern Medicine
After more than 20 years of hope and meaningful promises, this was the year scientists really showed they could doctor DNA to successfully treat diseases. Gene therapies are being used to treat cancer and even pull off the biblical-sounding feat of helping the blind to see were given the green light by U.S. regulators, establishing gene manipulation as a new mode of medicine.
BIOTECHSTOCKS,.com is owned by MIDAM VENTURES LLC., a Florida Corporation that has been compensated $950,000.00 by a GT Biopharma Inc. for a period beginning August 1, 2017 and ending Nov. 1, 2017 now extended to December 31, 2018 to publicly disseminate information about (GTBP). We own zero shares.